Abstract
The history of cancer medical treatments goes up to 1908 with the use of arsenic in this disease. An intermediate milestone was the discovery, in 1943, of an amazing tumor response using nitrogen mustard in a patient with a radio-resistant lymphoma. Chemotherapy really born with this achievement, and a plethora of antitumor agent’s came to age after 1948 till nowadays. Here, some examples of recent disease-oriented drug development approaches are presented and analyzed, as well as present limitations and challenges raised by each one
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Cancer Studies and Molecular Medicine – Open Journal
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
